Look for:

Products

CENTOGENE NV COM EUR0.12


ISIN:
NL0014040206
WKN:
N1976T109
2024/07/17 08:01:42
Price
0.4845 EUR
Difference 1.47% (0.01)

General attributes

ISINNL0014040206
SymbolCNTG
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)14 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.4845 EUR
High0.4845 EUR
Low0.4845 EUR
Close (prev. day)0.4775 EUR
VWAP0.33 EUR
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: CENTOGENE NV COM EUR0.12PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/07/17 08:01:42
Price
0.4845 EUR
Difference 1.47% (0.01)

General attributes

ISINNL0014040206
SymbolCNTG
ExchangeMunich
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)14 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open0.4845 EUR
High0.4845 EUR
Low0.4845 EUR
Close (prev. day)0.4775 EUR
VWAP0.33 EUR
Volume (pcs)0
Trading volume0.00
Number of trades2
Last size0

Performance and Risk

6m1Y3Y
Perf (%)-55.14%-64.11%-94.75%
Perf (abs.)-0.60-0.87-8.74
Beta0.700.670.72
Volatility82.5976.0693.84
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.4592 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)0.3865 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)0.4822 EUR (209)
Ø price 250 days | Ø volume 250 days (pcs.)0.8200 EUR (89)
YTD High | date1.1350 EUR (2024/01/18)
YTD Low | date0.3300 EUR (2024/06/03)
52 Weeks High | date1.4450 EUR (2023/12/13)
52 Weeks Low | date0.3300 EUR (2024/06/03)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/07/1720:300.474 EUR0.0019
Duesseldorf2024/07/1719:300.449 EUR0.007
Frankfurt2024/07/1709:100.4805 EUR0.002
Hamburg2024/07/1708:160.4805 EUR0.003
Munich2024/07/1708:010.4845 EUR0.002
Nasdaq2024/07/1722:300.53 USD0.0163
Stuttgart2024/07/1721:580.44 EUR0.008
Tradegate2024/07/1722:260.4905 EUR0.003

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=142389&ID_TYPE_IMAGE_LOGO=2

Contact Details

CENTOGENE NV
- -
Am Strande 7 - 18055 Rostock
Telefon: +49-381-80113400
Fax: +381-80113401
E-mail: -

PDF Downloads

Company report: CENTOGENE NV COM EUR0.12PDF Download

Company Profile

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.

Members of Management Board

Kim StrattonChairman of Managing Board
Ian RentschMember of Executive Committee
Miguel Coego RiosMember of Executive Committee
Peter BauerMember of Executive Committee

Board of directors

Peer SchatzChairman of Supervisory Board
Eric SouêtreMember of Supervisory Board
Hubert BirnerMember of Supervisory Board
Jonathan SheldonMember of Supervisory Board
Guido PrehnMember of Supervisory Board
Mary SheahanMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.